Extended-release morphine for chronic breathlessness in COPD: a randomized controlled trial with blinded up-titration over three weeks
M. Ekström (Lund, Sweden), D. Ferreira (Wollongong, Australia), S. Chang (Sydney, Australia), S. Louw (Sydney, Australia), M. Johnson (Hull, United Kingdom), D. Eckert (Adelaide, Australia), B. Fazekas (Sydney, Australia), K. Clark (Sydney, Australia), M. Agar (Sydney, Australia), D. Currow (Wollongong, Australia)
Source: International Congress 2022 – Clinical problems and management of airway diseases
Session: Clinical problems and management of airway diseases
Session type: Thematic Poster
Number: 1657
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Ekström (Lund, Sweden), D. Ferreira (Wollongong, Australia), S. Chang (Sydney, Australia), S. Louw (Sydney, Australia), M. Johnson (Hull, United Kingdom), D. Eckert (Adelaide, Australia), B. Fazekas (Sydney, Australia), K. Clark (Sydney, Australia), M. Agar (Sydney, Australia), D. Currow (Wollongong, Australia). Extended-release morphine for chronic breathlessness in COPD: a randomized controlled trial with blinded up-titration over three weeks. 1657
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|